PeaceHealth Southwest Hospital/Carson Tahoe Medical Center
Shock Defined
Cardiogenic Shock
Hypovolemic Shock
Obstructive Shock
Distributive Shock
Septic Shock
Post Cardiac Surgery Vasoplegia*
Emory Healthcare
Why Multimodal Shock Therapy?
Why Multimodal Shock Therapy?
Emory Healthcare Angiotensin II Protocol
Emory Healthcare Angiotensin II Protocol (cont)
Emory Healthcare Angiotensin II Protocol (cont)
The Emory Protocol
Emory Protocol Vasopressor Titration
Why This Protocol?
Issues With Protocol Implementation
George Washington University Hospital
Initial Assessment to Identify Type of Shock
Types of Shock
2018 SSC Bundle Update Hour-1
Vasopressors to Reach MAP ≥ 65 mm Hg
Organ Support
Hypovolemic Shock
Obstructive Shock
Cardiogenic Shock
Vasopressors in Cardiogenic Shock
Mayo Clinic
Mayo Clinic Patients Admitted to ICU Clinical Characteristics
ICU Patients on Vasopressors
Vasopressor Utilization Index (VUI)
VUI 2007 to 2013
Changes of VUI Temporal Relationship With Clinical Trials
Use of Different Vasopressor Based on the ICU Type
Trends of Specific Vasopressor Use
Use of Low-Dose Dopamine Dopamine Dose < 3 mcg/kg/min
Mayo Clinic Approach to Vasopressor Utilization: Steps to Be Taken Before Using Angiotensin II
1. Defining Refractory Distributive Shock
2. Ruling Out Cardiogenic Shock
3. Dose & Titration
4. Weaning Angiotensin II
Abbreviations
Abbreviations (cont)